0001104659-21-147745.txt : 20211208
0001104659-21-147745.hdr.sgml : 20211208
20211208182151
ACCESSION NUMBER: 0001104659-21-147745
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211108
FILED AS OF DATE: 20211208
DATE AS OF CHANGE: 20211208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Booker Harriet
CENTRAL INDEX KEY: 0001723978
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11993
FILM NUMBER: 211479804
MAIL ADDRESS:
STREET 1: C/O BIOSCRIP, INC.
STREET 2: 1600 BROADWAY, SUITE 700
CITY: DENVER
STATE: CO
ZIP: 80202
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Option Care Health, Inc.
CENTRAL INDEX KEY: 0001014739
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HOME HEALTH CARE SERVICES [8082]
IRS NUMBER: 050489664
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3000 LAKESIDE DR
STREET 2: SUITE 300N
CITY: BANNOCKBURN
STATE: IL
ZIP: 60015
BUSINESS PHONE: 312 940 2443
MAIL ADDRESS:
STREET 1: 3000 LAKESIDE DR
STREET 2: SUITE 300N
CITY: BANNOCKBURN
STATE: IL
ZIP: 60015
FORMER COMPANY:
FORMER CONFORMED NAME: BioScrip, Inc.
DATE OF NAME CHANGE: 20050314
FORMER COMPANY:
FORMER CONFORMED NAME: MIM CORP
DATE OF NAME CHANGE: 19960516
4
1
tm2134952d1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-11-08
0
0001014739
Option Care Health, Inc.
OPCH
0001723978
Booker Harriet
C/O OPTION CARE HEALTH, INC.
3000 LAKESIDE DRIVE, #300N
BANNOCKBURN
IL
60015
0
1
0
0
CHIEF OPERATING OFFICER
Common Stock, par value $0.0001
2021-11-08
4
M
0
6000
A
131974
D
Common Stock, par value $0.0001
2021-11-08
4
S
0
6000
27.93
D
125974
D
Common Stock, par value $0.0001
2021-12-06
4
M
0
6000
A
131974
D
Common Stock, par value $0.0001
2021-12-06
4
S
0
6000
24.81
D
125974
D
Employee Stock Option (Right to Buy)
10.12
2021-11-08
4
M
0
6000
0
D
Common Stock, par value $0.0001
6000
29249
D
Employee Stock Option (Right to Buy)
10.12
2021-12-06
4
M
0
6000
0
D
Common Stock, par value $0.0001
6000
23249
D
These stock options were granted on November 28, 2017, and vested and became exercisable in three equal installments commencing on the first anniversary of the grant date.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
The price reported in Table I, Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $27.91 to $27.98. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price.
/ s/ Clifford E. Berman, by power of attorney
2021-12-08